Navigation Links
Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Date:11/10/2008

erally well tolerated and continues to demonstrate encouraging activity with an impressive overall response rate and promising time to progression in these heavily pretreated, relapsed and refractory patients."

In addition to the KRX-0401 abstract which was selected for oral presentation, four abstracts on KRX-0401 were accepted for poster presentation. All of the clinical data to be presented demonstrates the potential efficacy of KRX-0401, both as a single agent and in combination with other approved agents, in the treatment of patients with multiple myeloma and waldenstrom's macroglobulinemia.

"We are encouraged by the safety and efficacy results obtained to date on the combination of KRX-0401 and bortezomib in relapsed and refractory multiple myeloma patients who were all previously treated with bortezomib," said Michael S. Weiss, Chairman and Chief Executive Officer of Keryx Biopharmaceuticals, Inc., who continued "we plan to further evaluate the potential efficacy of KRX-0401 as a treatment for multiple myeloma and related disorders and continue to explore the design of a phase 3 program in multiple myeloma."

Summary of KRX-0401 Data Presentations

ORAL PRESENTATION: TUESDAY, DECEMBER 9th

Abstract 870

Title: Phase I/II Results of a Multicenter Trial of Perifosine (KRX-0401)

+ Bortezomib in Patients with Relapsed or Relapsed / Refractory Multiple

Myeloma Who Were Previously Relapsed from or Refractory to Bortezomib

Session Name: Novel Therapies for Myeloma and Related Disorders Session

(7:00- 9:00 AM)

Presentation Time: 8:30am

Location: Gateway Ballroom 103 - South

Clinical Poster Presentations:

SATURDAY, DECEMBER 6th

Abstract 1010

TITLE: Final Results of a Phase II Trial of the Novel Oral Akt Inhibitor

Perifosine in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

(WM)

Session Name: Biologic Therapies for NHL (Ex
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
2. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
6. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
7. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
8. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
9. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
10. Lippincott Williams & Wilkins Selected as Publisher of the Journal of Neuroscience Nursing
11. Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... California (PRWEB) September 23, 2014 ... transcription is the process of translating the entire ... course, therapeutic procedures, and prognosis, into a readable ... agents, patients, and healthcare providers. With attending physicians ... each patient’s condition, outsourcing of such documentation to ...
(Date:9/23/2014)... go to Mars, will astronauts be able to grow ... they be able to produce food in NASA,s Orion ... growing food on Earth under extreme conditions? These are ... growth in microgravity on the International Space Station (ISS). ... fundamental genetic mechanisms plants use to adapt to a ...
(Date:9/23/2014)... NJ (PRWEB) September 23, 2014 Visiting ... provider of home health care, hospice and palliative care, ... to ring the Opening Bell last week at the ... a New Jersey philanthropist and social entrepreneur to care ... VNA Health Group has always worked to meet the ...
(Date:9/23/2014)... Becker's Hospital Review has published the 2014 edition ... Systems With Great Orthopedic Programs." , The hospitals ... orthopedic surgery departments, programs or dedicated centers that ... orthopedic departments include physicians who provide outstanding care ... athletes. , This is the fifth year Becker's ...
(Date:9/23/2014)... better screening strategies can lower the rate of false-positive ... on women. The many misperceptions about breast cancer screening ... and the need for new approaches and better education ... supplement to Journal of Women,s Health , a ... supplement is available free on the Journal of ...
Breaking Medicine News(10 mins):Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 2Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 3Health News:Getting to the root of the problem in space 2Health News:Getting to the root of the problem in space 3Health News:Getting to the root of the problem in space 4Health News:NJ's Largest Nonprofit Home Health Care Agency Joins Deutsche Bank to Ring New York Stock Exchange Opening Bell 2Health News:125 Hospitals With Great Orthopedic Programs 2Health News:125 Hospitals With Great Orthopedic Programs 3Health News:125 Hospitals With Great Orthopedic Programs 4Health News:125 Hospitals With Great Orthopedic Programs 5Health News:Opportunities to reduce patient burden associated with breast cancer screening 2
... in Attack and Stalking at Homes, OAKLAND, Calif., ... on a labor conference in Michigan Saturday night by ... Nurses Organizing Committee Monday called on SEIU,President Andrew Stern ... nurses, and working people for threats and harassment.", ...
... to,the State of Iowa,s new smoke-free law, the American ... Tobacco-Free" conference on April,29th in Coralville, Iowa to assist ... will offer information on the new law,and feature speakers ... businesses that have questions about the law and the ...
... identified in the blood of chronic sinusitis sufferers that ... disease, researchers say. , They used a sophisticated research ... proteins and found among 96 chronic sinusitis patients a ... can diagnose this disease with a totally objective test ...
... month, two,men from Massachusetts will begin The Elias Tembenis ... autism awareness and funds to,assist children with the diagnosis., ... walk approximately,3000 miles in honor of Elias Tembenis, a ... a seizure. Tembenis family friends,Williams and Genese hope to ...
... 14 A board-certified,radiologist, Fred Steinberg, M.D., his ... Fla., have reached a settlement with the United,States ... Justice Department,announced today. Under the terms of the ... resolves allegations that portions of CT scans were ...
... Region 5 has reached an agreement with American ... coal preparation,plant at 43521 Mayhugh Hill Road, Township ... includes a $40,000 penalty, resolves EPA,allegations that AEC ... at the plant that processes coal from a ...
Cached Medicine News:Health News:RNs Call on Service Employees Union (SEIU) President Stern to Renounce Violence Following Brutal Attack on Labor Event 2Health News:RNs Call on Service Employees Union (SEIU) President Stern to Renounce Violence Following Brutal Attack on Labor Event 3Health News:Potential blood test for chronic sinusitis identified 2Health News:Two Men to Walk Across America for Autism Aid, Awareness, and Loving Memory of Young Boy 2Health News:Florida Radiologist to Pay U.S. $7 Million to Resolve Fraud Claims 2
(Date:9/23/2014)... BOTHELL, Wash. , Sept. 23, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... announced two new additions to its Scientific Advisory Board.  ... and Anthony Davies , PhD. Dr. ...
(Date:9/22/2014)... BARCELONA, Spain , September 23, 2014 ... sponsors to meet health authorities, increasing rigor for trial ... The life sciences industry,s largest TMF survey to date ... sponsors that plan to provide auditors with remote access ... 32% of TMF owners surveyed in the ...
(Date:9/22/2014)... NEW YORK , Sept. 22, 2014 /PRNewswire/ ... is in mature stage. It is largely a ... endoscopy suite expansion. The mergers, acquisitions and partnerships ... Europe . This research service provides details ... competitive environment and pricing trends across the country. ...
Breaking Medicine Technology:BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3
... RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity ... today that it has entered into a definitive ... Clinical Innovations, LLC ("Clinical"), to The Pritzker Group, ...  Terms of the transaction were not disclosed. ...
... Amira Pharmaceuticals, Inc. announced today that it has ... lysophosphatidic acid (LPA)-related program, autotaxin.  Autotaxin is an enzyme ... a number of diseases including rheumatoid arthritis, glioblastoma, lung, ... pleased to announce that we have identified an orally ...
Cached Medicine Technology:RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group 2Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor 2
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Inquire...
Medicine Products: